Poster Competition
Eligibility
The Nashville Hematology Conference invites Medical Residents, Hematology or Oncology Fellows and Junior Faculty within 2 years of initial appointment to enter our Nashville Heme Poster Competition! Applicants may submit an abstract relevant to a hematologic malignancy and if selected, will present winning posters during the Welcome Reception on Thursday, February 26th, 2026 in Nashville, TN.
Attending the conference does not require a poster submission and/or presentation. Physician Fellows & Residents may attend at a discounted registration rate.
View the Poster Competition Terms & Conditions
Key Dates:
- Abstract submissions are due by October 31, 2025
- Winners will be notified by November 7, 2025
- Nashville Hematology Conference in Nashville, TN: February 26-28, 2026
Submissions to:
ScientificAffairs@ideologyhealth.com
by Friday, October 31, 2025, at 11:59 pm CT
Abstract Submission Guidelines:
- Abstract should be on the subject of hematologic malignancies
- Abstract should address scientific questions, detail clinical observations, or contain primary scientific data
- Abstract demonstrates originality and innovation
- Encores with updates are welcome
- Abstract is written clearly and concisely
- No Trials in Progress
- Abstract Body/Table: (please submit as an attachment to the submission email)
- Body of the abstract should include background, methods, results and conclusions
- Do not use proprietary drug names
- Submissions should not exceed 500 words. A table counts as 100 words
- One data table is allowed per submission
Judging:
- All submissions will be judged by the Nashville Heme Faculty who are established experts in the field. All submissions will be judged on scientific merit.
- Winners will be notified by Conference Planning Committee
- Winners will be asked to present their poster on Thursday, February 26th, 2026 during the Welcome Reception.
- Each winner will receive complimentary registration, two (2) nights accommodation, and up to $500 toward airfare as an award.
Complete Poster Competition Terms and Conditions are available at nashvilleheme.com/competition-terms
Title: Characterization of Cytokine Release Syndrome and Neurotoxicity in Commercially Available Bispecific Antibodies and Chimeric Antigen Receptor T-Cells in Multiple Myeloma
Title: A Tailored Treatment Algorithm in a Case of Four Co-existing Hematologic Malignancies
Title: Therapeutic challenges in Primary Refractory stage IV ALK + Large B-cell Lymphoma. A case report of a rare chemoresistant B-cell lymphoma overcome by checkpoint inhibition